| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |